David O Wilson
Overview
Explore the profile of David O Wilson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1356
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuan J, Kensler T, Dacic S, Hartman D, Wang R, Balogh P, et al.
Cancer Prev Res (Phila)
. 2025 Mar;
PMID: 40041932
Experimental studies have shown dietary isothiocyanates reduced cellular proliferative marker Ki-67 and increased apoptotic markers Caspase-3 and TUNEL in animals, but human data are lacking. The present study was to...
2.
Xiao D, Kammer M, Chen H, Woodhouse P, Sandler K, Baron A, et al.
Transl Lung Cancer Res
. 2024 Sep;
13(8):1907-1917.
PMID: 39263016
Background: Radiomics has shown promise in improving malignancy risk stratification of indeterminate pulmonary nodules (IPNs) with many platforms available, but with no head-to-head comparisons. This study aimed to evaluate transportability...
3.
Ash S, Doyle T, Choi B, San Jose Estepar R, Castro V, Enzer N, et al.
BMJ Open Respir Res
. 2024 Mar;
11(1).
PMID: 38485250
Introduction/rationale: Protein biomarkers may help enable the prediction of incident interstitial features on chest CT. Methods: We identified which protein biomarkers in a cohort of smokers (COPDGene) differed between those...
4.
Warkentin M, Al-Sawaihey H, Lam S, Liu G, Diergaarde B, Yuan J, et al.
Thorax
. 2024 Jan;
79(4):307-315.
PMID: 38195644
Background: Low-dose CT screening can reduce lung cancer-related mortality. However, most screen-detected pulmonary abnormalities do not develop into cancer and it often remains challenging to identify malignant nodules, particularly among...
5.
Somayajula S, Litake O, Liang Y, Hosseini R, Nemati S, Wilson D, et al.
Sci Rep
. 2024 Jan;
14(1):85.
PMID: 38168099
The emergence of long COVID during the ongoing COVID-19 pandemic has presented considerable challenges for healthcare professionals and researchers. The task of identifying relevant literature is particularly daunting due to...
6.
Marmor H, Kammer M, Deppen S, Shipe M, Welty V, Patel K, et al.
J Thorac Cardiovasc Surg
. 2023 Feb;
166(3):669-678.e4.
PMID: 36792410
Objective: Indeterminate pulmonary nodules (IPNs) represent a significant diagnostic burden in health care. We aimed to compare a combination clinical prediction model (Mayo Clinic model), fungal (histoplasmosis serology), imaging (computed...
7.
Stacy S, Chandra H, Guha S, Gurewitsch R, Brink L, Robertson L, et al.
BMC Public Health
. 2023 Jan;
23(1):184.
PMID: 36707789
Background: Local governments and other public health entities often need population health measures at the county or subcounty level for activities such as resource allocation and targeting public health interventions,...
8.
Marmor H, Deppen S, Welty V, Kammer M, Godfrey C, Patel K, et al.
Cancer Epidemiol Biomarkers Prev
. 2022 Dec;
32(3):329-336.
PMID: 36535650
Background: Indeterminate pulmonary nodules (IPN) are a diagnostic challenge in regions where pulmonary fungal disease and smoking prevalence are high. We aimed to determine the impact of a combined fungal...
9.
Zhai T, Diergaarde B, Wilson D, Kang H, Sood A, Bayliss S, et al.
Am J Obstet Gynecol
. 2022 Aug;
227(6):885.e1-885.e12.
PMID: 35934119
Background: Early natural menopause has been regarded as a biomarker of reproductive and somatic aging. Cigarette smoking is the most harmful factor for lung health and also an established risk...
10.
Choi B, Adan N, Doyle T, San Jose Estepar R, Harmouche R, Humphries S, et al.
Chest
. 2022 Jul;
163(1):164-175.
PMID: 35780812
Background: The risk factors and clinical outcomes of quantitative interstitial abnormality progression over time have not been characterized. Research Questions: What are the associations of quantitative interstitial abnormality progression with...